Patent ID: 11911473
Assignee: AZURITY PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a gastrointestinal disorder in a subject in need thereof, the method comprising:
administering a reconstituted proton pump inhibitor oral liquid formulation to the subject, wherein the reconstituted proton pump inhibitor oral liquid formulation comprises a proton pump inhibitor and a liquid diluent, and wherein the liquid diluent comprises:
a poloxamer, sodium carboxymethylcellulose (CMC), sodium bicarbonate, a buffering agent, simethicone emulsion, a preservative, a sweetener, water, and optionally one or more excipients selected from a flavoring agent and a coloring agent,
wherein the liquid diluent is stable for at least 30 days at 5±3° C.